Stay updated with breaking news from Sciences Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exact Sciences Co. (NASDAQ:EXAS – Get Rating) reached a new 52-week high during trading on Tuesday . The stock traded as high as $95.65 and last traded at $94.19, with a volume of 419660 shares trading hands. The stock had previously closed at $93.42. Analyst Upgrades and Downgrades A number of analysts have commented on […]
Exact Sciences Co. (NASDAQ:EXAS – Get Rating) has received a consensus rating of “Moderate Buy” from the thirteen ratings firms that are currently covering the firm, Marketbeat reports. Four equities research analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 12-month price target […]
Exact Sciences Co. (NASDAQ:EXAS – Get Rating) Director James Edward Doyle sold 1,402 shares of Exact Sciences stock in a transaction dated Friday, June 9th. The stock was sold at an average price of $90.51, for a total transaction of $126,895.02. Following the completion of the transaction, the director now directly owns 54,110 shares of […]
ExodusPoint Capital Management LP trimmed its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 17.8% during the fourth quarter, Holdings Channel reports. The firm owned 58,292 shares of the medical research company’s stock after selling 12,600 shares during the period. ExodusPoint Capital Management LP’s holdings in Exact Sciences were worth $2,886,000 […]
Thematics Asset Management bought a new stake in Exact Sciences Co. (NASDAQ:EXAS – Get Rating) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 47,771 shares of the medical research company’s stock, valued at approximately $2,365,000. A number of other institutional investors have also […]